Enantioselective synthesis of hyperparathyroidism agent Cinacalcet hydrochloride

被引：0
|
作者：
Ganesh, N. S. [1 ]
Spandana, K. V. L. D. [1 ]
Narsaiah, A. Venkat [1 ]
机构：
[1] CSIR, Fluoro Agrochan Dept, Organ Synth Lab, Indian Inst Chem Technol, Hyderabad 500007, India
来源：
INDIAN JOURNAL OF CHEMISTRY | 2022年 / 61卷 / 05期
关键词：
Wittig reaction; CBS-reduction; oxidation; reductive amination; hyperparathyroidism; CALCIMIMETIC AGENT; ALDEHYDES; EFFICIENT; ALCOHOLS; ROUTE;
D O I：
暂无
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
A simple and efficient route has been developed for enantioselective synthesis of hyperparathyroidism agent (R)-Cinacalcet. The synthesis started from commercially available triflouromethyl benzaldehyde and 1-(naphthalen-1-yl) ethanone and completed in 8 steps with an overall yield 18.5%. The key reactions involved are Corey-Bakshi-Shibata chiral reduction and reductive amination.
引用
收藏
页码：503 / 507
页数：5
相关论文
共 50 条
  • [21] Cinacalcet hydrochloride
    不详
    DRUG NEWS & PERSPECTIVES, 2003, 16 (07) : 470 - 470
  • [22] Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication
    Marotta, Vincenzo
    Di Somma, Carolina
    Rubino, Manila
    Sciammarella, Concetta
    Del Prete, Michela
    Marciello, Francesca
    Ramundo, Valeria
    Circelli, Luisa
    Buonomano, Pasqualina
    Modica, Roberta
    Vitale, Mario
    Colao, Annamaria
    Faggiano, Antongiulio
    ENDOCRINE, 2015, 49 (01) : 274 - 278
  • [23] Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis
    Charytan, C
    Coburn, JW
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, PS
    McCary, LC
    Pichette, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) : 58 - 67
  • [24] Practical synthesis of the calcimimetic agent, cinacalcet
    Thiel, Oliver R.
    Bernard, Charles
    Tormos, Wanda
    Brewin, Alan
    Hirotani, Shuji
    Murakaini, Kazuo
    Saito, Kenji
    Larsen, Robert D.
    Martinelli, Michael J.
    Reider, Paul J.
    TETRAHEDRON LETTERS, 2008, 49 (01) : 13 - 15
  • [25] Cinacalcet in severe hyperparathyroidism
    Fluck, Richard
    Taal, Maarten
    McIntyre, Christopher
    Symes, Fiona
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 128 - 129
  • [26] CINACALCET AND TERTIARY HYPERPARATHYROIDISM
    Nasr, Rabih
    Saifan, Chadi
    El-Sayegh, Suzanne
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (04) : A60 - A60
  • [27] Industrial Application of the Forster Reaction: Novel One-Pot Synthesis of Cinacalcet Hydrochloride, a Calcimimetic Agent
    Shinde, Gorakshanath B.
    Niphade, Navnath C.
    Deshmukh, Shrikant P.
    Toche, Raghunath B.
    Mathad, Vijayavitthal T.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (02) : 455 - 461
  • [28] Cost-Effectiveness of Cinacalcet Hydrochloride for Hemodialysis Patients With Severe Secondary Hyperparathyroidism in Japan
    Komaba, Hirotaka
    Moriwaki, Kensuke
    Goto, Shunsuke
    Yamada, Shunsuke
    Taniguchi, Masatomo
    Kakuta, Takatoshi
    Kamae, Isao
    Fukagawa, Masafumi
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (02) : 262 - 271
  • [29] Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism
    Yasuhiro Takeuchi
    Shunsuke Takahashi
    Daishu Miura
    Makoto Katagiri
    Noriaki Nakashima
    Hiroko Ohishi
    Ryutaro Shimazaki
    Yoshihiro Tominaga
    Journal of Bone and Mineral Metabolism, 2017, 35 : 616 - 622
  • [30] A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
    Hironori Nakamura
    Masanori Tokumoto
    Mariko Anayama
    Shigekazu Kurihara
    Yasushi Makino
    Katsuhiko Tamura
    Masaki Nagasawa
    CEN Case Reports, 2022, 11 : 254 - 258
12345